The majority of TEAEs were slight or moderate
The majority of TEAEs were slight or moderate. of subjects in the ABP 710, infliximab US, and infliximab EU treatment organizations, respectively; incidence of antidrug antibody rates observed across the 3 organizations were similar. Results of this study shown pharmacokinetic similarity of DAA-1106 ABP 710 with infliximab RP following a solitary 5\mg/kg intravenous injection. The…